Atrial fibrillation: new findings about an old nemesis.
Atrial fibrillation has been found to be a significant risk factor for stroke independent of the contribution this common arrhythmia makes via its previously established stroke risk factors. Results of four recent trials in patients with nonrheumatic atrial fibrillation show that warfarin anticoagulant therapy can substantially reduce the risk of stroke without major bleeding complications.
Boston University.
M D
MD
Klein
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002561:Cerebrovascular Disorders / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D006801:Humans; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D004071:Digitalis Glycosides